Preferred Label : Elapegademase;
NCIt synonyms : Methoxypolyethylene Glycol Recombinant Adenosine Deaminase; SC-PEG rADA; Elapegademase-lvlr;
NCIt definition : A recombinant form of the enzyme adenosine deaminase (rADA), based on the bovine amino
acid sequence and covalently conjugated, with a succinimidyl carbamate linker, to
monomethoxypolyethylene glycol (mPEG) (SC-PEG rADA), that can be used as an enzyme
replacement agent for the treatment of adenosine deaminase severe combined immune
deficiency (ADA-SCID). Upon intramuscular administration, elapegademase, as an exogenous
source of ADA, replaces the deficient ADA enzyme and acts in the same manner as the
endogenous enzyme. ADA is involved in purine metabolism and mainly catalyzes the irreversible
hydrolytic deamination of adenosine or deoxyadenosine to inosine or deoxyinosine,
respectively, as well as several naturally occurring methylated adenosine compounds.
Elapegademase decreases toxic levels of adenosine and deoxyadenosine nucleotides,
increases lymphocyte levels and helps maintain the proper functioning of immune cells.
Elevated adenosine levels, as seen in ADA deficiency, induce apoptosis and inhibit
the differentiation of thymocytes, resulting in T-lymphopenia. Low levels of deoxyadenosine
and adenosine play key roles in the regulation of lymphocyte levels and the proper
functioning of immune cells.;
UNII : 9R3D3Y0UHS;
CAS number : 1709806-75-6;
Drug name : Revcovi;
NCI Metathesaurus CUI : CL1405959;
Origin ID : C171787;
UMLS CUI : C4731737;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
concept_is_in_subset